Vivo Capital, LLC

Vivo Capital, LLC reported 47 holdings worth US$1.1B as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 14, 2026

Vivo Capital, LLC reported 47 holdings worth US$1.1B as of Jun 30, 2026. Largest: Trevi Therapeutics, Inc., Praxis Precision Medicines, Inc. and Erasca, Inc. Filed Aug 14, 2026 (Form 13F).

Holdings
47
Value as reported
US$1.1B

The filing in full

CompanySharesValue as reported% of portfolio
Trevi Therapeutics, Inc.5.09MUS$95M8.7%
Praxis Precision Medicines, Inc.271KUS$90.8M8.3%
Erasca, Inc.4.13MUS$75.6M6.9%
Arrivent Biopharma, Inc.1.68MUS$58.4M5.3%
Abivax Sa415KUS$55.3M5.0%
Tango Therapeutics, Inc.1.38MUS$43.1M3.9%
Corvus Pharmaceuticals, Inc.2.81MUS$41.9M3.8%
Bright Minds Biosciences Inc.557KUS$39.1M3.6%
Sinovac Biotech, Ltd.5.9MUS$38.2M3.5%
Tenax Therapeutics, Inc.2.5MUS$36.4M3.3%
Aclaris Therapeutics, Inc.6.69MUS$35.4M3.2%
Dyne Therapeutics, Inc.1.56MUS$34.6M3.2%
Dianthus Therapeutics, Inc.354KUS$34.5M3.2%
Alto Neuroscience, Inc.1.21MUS$31.9M2.9%
Dbv Technologies Sa1.84MUS$30.3M2.8%
Sab Biotherapeutics, Inc.7.3MUS$28.5M2.6%
Lb Pharmaceuticals Inc800KUS$26M2.4%
Minerva Neurosciences, Inc4.32MUS$24M2.2%
Design Therapeutics, Inc.1.61MUS$23.3M2.1%
Oric Pharmaceuticals, Inc.1.85MUS$20M1.8%
Camp4 Therapeutics Corporation4.25MUS$18.6M1.7%
Sensei Biotherapeutics, Inc.722KUS$18.1M1.6%
Achieve Life Sciences, Inc.2.75MUS$18M1.6%
Compass Therapeutics, Inc.7.76MUS$17M1.6%
An2 Therapeutics, Inc.3.15MUS$15.3M1.4%
Editas Medicine, Inc.3.56MUS$11.5M1.1%
Geron Corporation8.67MUS$11.1M1.0%
Odyssey Therapeutics, Inc.575KUS$10.8M0.98%
Eupraxia Pharmaceuticals, Inc.1.35MUS$8.92M0.81%
Onkure Therapeutics, Inc.1.93MUS$8.79M0.80%
Olema Pharmaceuticals, Inc.672KUS$8.4M0.77%
Monopar Therapeutics Inc.90,500US$8.38M0.77%
Aura Biosciences, Inc.1.17MUS$8.28M0.76%
Surrozen, Inc.260KUS$6.75M0.62%
Alx Oncology Holdings Inc.3.18MUS$6.59M0.60%
Satellos Bioscience Inc814KUS$6.33M0.58%
Avalo Therapeutics, Inc.275KUS$5.08M0.46%
Pepgen Inc.2.33MUS$4.18M0.38%
Valneva Se763KUS$3.99M0.36%
Sera Prognostics, Inc.1.65MUS$3M0.27%
Unicycive Therapeutics, Inc.550KUS$2.58M0.24%
Instil Bio, Inc.293KUS$2.25M0.21%
Inmed Pharmaceuticals Inc.798KUS$1.24M0.11%
Bolt Biotherapeutics, Inc.72,414US$279K0.03%
Pasithea Therapeutics Corp.465KUS$240K0.02%
Precision Biosciences, Inc.4,675US$36,746<0.01%
Terns Pharmaceuticals, Inc.0US$00.00%
Veradermics, Incorporated0US$00.00%
Viridian Therapeutics, Inc.0US$00.00%
Soleno Therapeutics, Inc.0US$00.00%
Cogent Biosciences, Inc.0US$00.00%

Source

View original at SEC

Related